US20040013738A1 - Encapsulation of liquid template particles - Google Patents
Encapsulation of liquid template particles Download PDFInfo
- Publication number
- US20040013738A1 US20040013738A1 US10/343,583 US34358303A US2004013738A1 US 20040013738 A1 US20040013738 A1 US 20040013738A1 US 34358303 A US34358303 A US 34358303A US 2004013738 A1 US2004013738 A1 US 2004013738A1
- Authority
- US
- United States
- Prior art keywords
- shell
- liquid
- template particles
- polyelectrolyte
- previous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/10—Complex coacervation, i.e. interaction of oppositely charged particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/20—After-treatment of capsule walls, e.g. hardening
- B01J13/22—Coating
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Definitions
- the invention concerns a method for applying a shell to liquid template particles.
- a method for applying a shell to liquid template particles comprising the steps (a) providing an emulsion of liquid template particles in a continuous liquid or gel phase whereby at least one amphiphilic polyelectrolyte or polyelectrolyte complex or/and at least one copolymer of charged hydrophilic monomers and oil-soluble monomers is dissolved in the liquid template particles or/and the continuous phase thus forming a film at the phase boundary between the liquid template particle and the continuous phase and (b) applying a shell to the film formed at the phase boundary.
- the encapsulation process according to the invention enables the encapsulation of any colloidal liquid particles e.g. emulsified oil droplets in a continuous aqueous or non-aqueous liquid phase.
- An oil phase is particularly preferably used as the liquid template particles and an aqueous phase e.g. a salt-containing aqueous solution in which the salt concentration is preferably between 0.001 mM and 1 M or more is particularly preferably used as the continuous liquid phase.
- an aqueous phase e.g. a salt-containing aqueous solution in which the salt concentration is preferably between 0.001 mM and 1 M or more is particularly preferably used as the continuous liquid phase.
- the process also allows the use of continuous gel phases and in particular aqueous gel phases.
- An essential feature of the present invention is that a film is formed at the boundary between the template particle and continuous liquid phase.
- a polyelectrolyte or polyelectrolyte complex can be used for this purpose which is soluble in the oil phase.
- the polyelectrolyte or polyelectrolyte complex can also be dissolved in the continuous liquid phase e.g. an aqueous phase.
- surface-active copolymers which contain monomers of different polarity.
- simplex compounds can be used as amphiphilic polyelectrolytes which contain (a) polycationic polymers and anions, for example monomeric anions such as salts of organic acids e.g. carboxylic acids or even polymeric anions such as polyacrylates or (b) polyanionic polymers and cations e.g. cationic monomers or polymers.
- the oleophilic behaviour of these types of compound can be influenced by the selection of the corresponding counterion for the polymer.
- polyfunctional zwitterionic surfactants which are also amphiphilic compounds. In special cases it is possible to use combinations of polyfunctional surfactants and polyelectrolyte/counterion pairs.
- the concentration of the polyelectrolyte is preferably up to a maximum of 2% by weight, particularly preferably 0.01 to 1% by weight based on the total weight of the liquid template particle.
- concentration of the polyelectrolyte is preferably up to a maximum of 2% by weight, particularly preferably 0.01 to 1% by weight based on the total weight of the liquid template particle.
- amphiphilic polyelectrolytes are simplex compounds of polycations containing ammonium ions and hydrophobic organic anions such as the salts of organic acids e.g. carboxylic acids having 10 or more carbon atoms or polyanions such as polyacrylate or polymethacrylate.
- poly(diallyl-dimethyl)ammonium stearate, palmitate, oleate or ricinolate poly[alkyl-methyl-bis(polyoxyethylene)-ammonium]-polyacrylate or poly[alkyl-dihydroxyethyl-ethyl-ammonium]-polyacrylate where the molecular weight of the polycation is preferably ⁇ 150,000 D and particularly preferably ⁇ 200,000 D.
- suitable polyfunctional surfactants are amphiphilic polymers with cationic ammonium groups and anionic sulfinate, sulfonate, sulfate, phosphonate, phosphate or/and carboxylate groups.
- Suitable surfactants are alkyl-bis(polyoxyethylene)-ammonium-sulfobetaine-sulfinate, alkyl-bis(polyoxyethylene)-ammonium-sulfobetaine-sulfonate, ethylated alkyl- or dialkyl-ammonium betaine or alkyldimethyl-ammonium-propyl-modified polysiloxanes or siloxane-sulfobetaine-sulfones.
- the emulsion drops to be coated can have a size of up to 50 ⁇ m.
- the size of the drops is preferably up to 10 ⁇ m, particularly preferably 5 nm to 10 ⁇ m and most preferably 5 nm to 5 ⁇ m.
- the size of the drops can be adjusted by suitable treatment methods e.g. ultrasound, emulsification with a dispersing agent, extrusion or/and by adding surface-active substances to the continuous liquid phase.
- the liquid template particles may be a homogeneous liquid. They can, however, also comprise a solution, an emulsion or a suspension. Furthermore the liquid template particles can consist of a liquid-crystalline substance or contain such a substance. In a preferred embodiment template particles are encapsulated which contain an active substance e.g. they themselves represent an active substance. In general active substances can be encapsulated which are dissolved or dispersed in the liquid template particle.
- the active substance can for example be selected from catalysts, polymers, dyes, sensor molecules, flavourings, pharmaceutical agents, herbicides, insecticides, fungicides, oils in particular pharmaceutical or cosmetic oils e.g. perfume oils or solids that are soluble in oil or can be dispersed in oil, in particular pharmaceutical active substances.
- Organic liquids such as alcohols or hydrocarbons e.g. hexanol, octanol, octane or decane can also for example be encapsulated.
- Such capsules filled with an organic liquid that is not miscible with water can also be used for chemical reactions e.g. polymerization reactions.
- the monomer can be concentrated specifically in the inner space of the capsules as a result of its distribution equilibrium.
- the method according to the invention enables the production of capsules for enclosing active substances.
- the inner space can be loaded with molecules by varying the permeability of the shell as a function of the external physical and chemical parameters. A state of high permeability is adjusted for loading purposes.
- the enclosed material is subsequently retained by changing the external parameters or/and closing the pores for example by condensing the shell or by chemical or/and thermal modification of the pores or channels.
- the method according to the invention allows charged or/and uncharged components to be deposited on the template particles.
- the components required to form the shell contain at least one polyelectrolyte for example two oppositely charged polyelectrolytes or/and a polyvalent metal cation and a negatively charged polyelectrolyte.
- Polyelectrolytes are generally understood to mean polymers having ionically dissociable groups which may be a component or substituent of the polymer chain.
- the number of these ionically dissociable groups in the polyelectrolytes is usually large enough to ensure the water-solubility of the polymers in a dissociated form (also referred to as polyions).
- the term polyelectrolyte as used herein also refers to ionomers in which the concentration of the ionic groups is not sufficient to make them water soluble, but which have sufficient charges for a self-assembly.
- the shell preferably contains “true” polyelectrolytes.
- Polyelectrolytes are divided into polyacids and polybases depending on the type of the dissociable groups.
- Polyanions which can be inorganic as well as organic polymers are formed from polyacids when they dissociate with cleavage of protons.
- Polybases contain groups which are able to accept protons e.g. by reaction with acids to form salts. Polybases can have groups in the chains or side groups that are dissociable and form polycations by accepting protons.
- Polyelectrolytes that are suitable according to the invention are biopolymers such as alginic acid, gum arabic, nucleic acids, pectins, proteins and other biopolymers that may be chemically modified such as ionic or ionizable polysaccharides e.g. carboxymethyl cellulose, chitosan and chitosan sulfate, lignin sulfonates and synthetic polymers such as polymethacrylic acid, polyvinylsulfonic acid, polyvinylphosphonic acid and polyethyleneimine.
- biopolymers such as alginic acid, gum arabic, nucleic acids, pectins, proteins and other biopolymers that may be chemically modified such as ionic or ionizable polysaccharides e.g. carboxymethyl cellulose, chitosan and chitosan sulfate, lignin sulfonates and synthetic polymers such as polymethacrylic acid, poly
- Suitable polyanions comprise naturally occurring polyanions and synthetic polyanions.
- naturally occurring polyanions are alginate, carboxymethylamylose, carboxymethylcellulose, carboxymethyldextran, carageenan, cellulose sulfate, chrondroitin sulfate, chitosan sulfate, dextran sulfate, gum arabic, guar gum, gellan gum, heparin, hyaluronic acid, pectin, xanthan and proteins at an appropriate pH.
- Examples of synthetic polyanions are polyacrylates (salts of polyacrylic acid), anions of polyamino acids and copolymers thereof, polymaleinate, polymethacrylate, polystyrene sulfate, polystyrene sulfonate, polyvinyl phosphate, polyvinyl phosphonate, polyvinyl sulfate, polyacrylamidemethylpropane sulfonate, polylactate, poly(butanediene/maleinate), poly(ethylene/maleinate), poly(ethacrylate/acrylate) and poly(glycerylmethacrylate).
- Suitable polybases comprise naturally occurring polycations and synthetic polycations.
- suitable naturally occurring polycations are chitosan, modified dextrans, e.g. diethylaminoethyl-modified dextrans, hydroxymethylcellulose trimethylamine, lysozyme, polylysine, protamine sulfate, hydroxyethylcellulose trimethylamine and proteins at appropriate pH values.
- Examples of synthetic polycations are polyallyl-amine, polyallylamine hydrochloride, polyamines, polyvinylbenzyl-trimethyl-ammonium chloride, polybrene, polydiallyldimethylammonium chloride, poly-ethyleneimine, polyimidazoline, polyvinylamine, polyvinylpyridine, poly(acryl-amide/methacryloxypropyltrimethylammonium bromide), poly(diallyldimethyl-ammonium chloride/N-isopropylacrylamide), poly(dimethylaminoethylacrylate/acrylamide), polydimethylaminoethylmethacrylate, polydimethylaminoepichlorohydrin, polyethyleneiminoepichlorohydrin, polymethacryloxyethyltrimethylammonium bromide, hydroxypropylmethacryloxyethyldimethylammonium chloride, poly(methyldiethylaminoethylmethacrylate/acryl
- Linear or branched polyelectrolytes can be used.
- the use of branched polyelectrolytes leads to less compact polyelectrolyte multifilms having a high degree of wall porosity.
- the capsule stability can be increased by cross-linking polyelectrolyte molecules within or/and between the individual layers e.g. by cross-linking amino groups with aldehydes.
- amphiphilic polyelectrolytes e.g. amphiphilic block or random copolymers having a partial polyelectrolyte character.
- amphiphilic copolymers consist of units of different functionality e.g. acidic or basic units on the one hand and hydrophobic units on the other hand such as styrenes, dienes or siloxanes etc. which can be arranged as blocks or randomly distributed over the polymer.
- the permeability or other properties of the capsule walls can be adjusted in a defined manner by using copolymers which change their structure as a function of the external conditions.
- These may for example be weak polyelectrolytes, polyampholytes or copolymers having a poly(N-isopropylacrylamide) component e.g. poly(N-isopropylacrylamide acrylic acid) which due to the equilibrium of hydrogen bridges, change their water solubility as a function of the temperature which is associated with swelling.
- a poly(N-isopropylacrylamide) component e.g. poly(N-isopropylacrylamide acrylic acid) which due to the equilibrium of hydrogen bridges, change their water solubility as a function of the temperature which is associated with swelling.
- the release of enclosed active substances can be regulated via the disintegration of the capsule walls by using polyelectrolytes that can be degraded under certain conditions e.g. photolabile, acid-labile, base-labile, salt-labile or thermolabile polyelectrolytes.
- polyelectrolytes that can be degraded under certain conditions e.g. photolabile, acid-labile, base-labile, salt-labile or thermolabile polyelectrolytes.
- conductive polyelectrolytes or polyelectrolytes having optically active groups can be used as capsule components for special applications.
- the properties and composition of the polyelectrolyte shell of the capsules according to the invention can be adjusted in a defined manner by suitable selection of the polyelectrolytes.
- the composition of the shells can be varied over a wide range by selection of substances for the layer structure. There are basically no limitations with regard to the polyelectrolytes or ionomers that are used provided the molecules have a sufficient charge or/and the ability to bind to the underlying layer by other types of interaction such as hydrogen bonds and/or hydrophobic interactions.
- suitable polyelectrolytes are low molecular polyelectrolytes or polyions and also macromolecular polyelectrolytes such as polyelectrolytes of biological origin.
- the permeability of the shell wall is of particular importance for the use of the capsules.
- the large number of polyelectrolytes that are available enables the production of numerous shell compositions having different properties.
- the electric charge of the outer shell can be adapted to the intended use.
- the inner shell can be adapted to the respective encapsulated active substances which can for example lead to a stabilization of the active substance.
- the permeability of the shell wall can be influenced by the selection of the polyelectrolytes in the shell and by the wall thickness as well as ambient conditions. This enables a selective design of the permeability properties and a defined change in these properties.
- the permeability properties of the shell can be further modified by pores in at least one of the polyelectrolyte layers. Such pores can be formed by the polyelectrolytes themselves if a suitable choice is made.
- the shell can also contain other substances in order to achieve a desired permeability.
- the permeability to polar components can be lowered by incorporating nanoparticles having anionic or/and cationic groups or surface-active substances such as surfactants or/and lipids.
- the incorporation of selective transport systems such as carriers or channels in the polyelectrolyte shell and in particular in lipid layers enables an exact adaptation of the transversal transport properties of the shell to the respective intended use.
- the pores or channels of the shell wall can be opened or closed in a specific manner by chemical modification or/and change of the ambient conditions. Thus for example a high salt concentration of the surrounding medium leads to a high permeability of the shell wall.
- a first embodiment of the method according to the invention comprises the application of polyelectrolytes in layers on the liquid template particles that have been pretreated by adding amphiphilic polyelectrolytes.
- the application of polyelectrolytes in layers preferably comprises several and in particular more than four process steps in which oppositely charged polyelectrolytes are successively deposited from the continuous liquid phase onto the template particle.
- a second embodiment of the method according to the invention comprises a complex precipitation of multilayers or coacervation of several e.g. two oppositely charged polyelectrolytes.
- the coating components in a complexed form are added first to the coating emulsion e.g. as complexes of two oppositely charged polyelectrolytes, and the components are transferred (redistributed) onto the boundary layer between the template particle and continuous phase by changing the media conditions.
- the film-forming components are for example kept in a solution e.g. in an alkaline solution in which the two are present simultaneously but without reacting with one another.
- the template particles to be coated are added to this solution.
- the template particles can be dissolved if necessary.
- acid e.g. HCl
- the surface precipitation can occur from a solution containing a complex consisting of a low-molecular ion and an oppositely charged polyelectrolyte.
- suitable low-molecular ions are metal cations, inorganic anions such as sulfate, carbonate, phosphate, nitrate etc., charged surfactants, charged lipids and charged oligomers in combination with an appropriate oppositely charged polyelectrolyte.
- a dispersed source for the one polyelectrolyte is generated in this process while the other polyelectrolyte is present at the same time.
- the polyelectrolyte of the complex can be the polycation as well as the polyanion.
- a positively charged polyelectrolyte with a multiply negatively charged low-molecular anion e.g. sulfate is added to a solution of the negatively charged polyelectrolyte and a suspension of the template particles which results in a coating of the template particles.
- the coated template particles can for example be separated from the free complexes by centrifugation, filtration and subsequent washing and—provided they are soluble particles—be dissolved to produce microcapsules.
- Another preferred embodiment comprises surface precipitation from a solution containing partially destabilized polyelectrolyte complexes (polycation/polyanion) by adding salt or/and pH variation.
- polycation/polyanion partially destabilized polyelectrolyte complexes
- this process there is a gradual transfer of polyelectrolytes from the complexes onto the template surface.
- This can be accomplished by introducing and stirring the negatively and positively charged polyelectrolyte in an aqueous solution having a high salt content preferably a salt content of ⁇ 0.5 mol/l, e.g. 1 M NaCl.
- the template particles are coated after addition to the solution.
- the coated template particles can for example be isolated by centrifugation, filtration, sedimentation or other known phase separation methods and, subsequent washing and optionally dissolved to generate microcapsules.
- the shell comprises low-molecular cations e.g. metal cations and at least one negatively charged polyelectrolyte.
- Divalent cations and in particular trivalent cations are for example used as cations.
- suitable cations are alkaline earth metal cations, transition metal cations and rare earth element cations such as Ca 2+ , Mg 2+ , Y 3+ , Tb 3+ and Fe 3+ .
- monovalent cations such as Ag + .
- Template particles coated with a metal layer can be produced by reducing the metal cations.
- the components that are necessary to form the shell comprise at least one macromolecule e.g. an abiogenic macromolecule such as an organic polymer or a biomolecule such as a nucleic acid e.g. DNA, RNA or a nucleic acid analogue, a polypeptide, a glycoprotein or a polysaccharide having a molecular weight of preferably ⁇ 5 kD, and particularly preferably of ⁇ 10 kD.
- the macromolecules can carry charges such as nucleic acids or be uncharged such as polysaccharides e.g. dextran.
- the macromolecules can optionally be combined with polyelectrolytes or/and polyvalent metal cations in which case combinations of macromolecular and low-molecular biological cell substances, macromolecular and low-molecular abiogenic substances and macromolecular and biogenic and abiogenic substances can for example be used.
- the components that are added to form the shell comprise a mixture of several polyelectrolytes or/and lipids or/and proteins or/and peptides or/and nucleic acids or/and other organic and inorganic compounds of biogenic or abiogenic origin.
- a suitable composition of the liquid continuous phase with regard to salt content, pH value, cosolvents, surfactants and a suitable selection of the coating conditions e.g. temperature, rheological conditions, presence of electrical or/and magnetic fields, presence of light etc. results in a self-assembly of the diverse shell components on the templates to form complex structures having a wide variety of biomimetic properties.
- step (b) of the method according to the invention occurs under conditions such that a shell of a defined thickness is formed around the template which is in the range of 1 to 100 nm, preferably 1 to 50 nm, particularly preferably 5 to 30 nm and most preferably 10 to 20 nm.
- the wall thickness and the homogeneity of the capsule shell are determined by the number and composition of the layers and by the precipitation process, which essentially depends on the concentration of the template particles, the concentration of the coating components and the rate of the solubility change in the liquid phase which causes the precipitation.
- An application by means of precipitation can for example be carried out by firstly adding a part of the components forming the shell to the liquid phase and subsequently adding one or more additional shell components.
- a precipitation step can for example be used for a combination of metal cations and oppositely charged polyelectrolytes.
- Another method of precipitation is that the components required to form the shell are already completely present in the liquid phase and a change in the liquid phase occurs which results in the precipitation.
- This change in the liquid phase can for example comprise a change of the pH value and/or a change in the composition of the liquid phase e.g. by adding a solvent component or/and removing a solvent component.
- hydrophilic biopolymers such as DNA or polysaccharides can be precipitated by adding ethanol to an aqueous liquid phase
- polyelectrolyte combinations can be precipitated by evaporating off an organic solvent such as acetone from the liquid phase.
- the components used to form the shell can alternatively or in addition also comprise nanoparticles e.g. organic or inorganic nanoparticles, in particular nanoparticles having electrical, magnetic or optical properties e.g. magnetite or CdTe.
- nanoparticles e.g. organic or inorganic nanoparticles, in particular nanoparticles having electrical, magnetic or optical properties e.g. magnetite or CdTe.
- the coating method according to the invention can additionally comprise at least one additional coating step before or/and after the precipitation step.
- Such an additional coating step can for example comprise the application of one or more lipid layers or/and the application of layers of polyelectrolytes.
- the permeability of a shell can be modified by depositing lipid layers or/and amphiphilic polyelectrolytes on the polyelectrolyte shell. This can result in a very substantial reduction of the permeability of the shells to small and polar molecules.
- lipids that can be deposited on the shells are lipids which carry at least one ionic or ionogenic group e.g. phospholipids such as dipalmitoylphosphatidic acid or zwitterionic phospholipids such as dipalmitoylphosphatidyl choline or fatty acids or corresponding long chain alkylsulfonic acids.
- phospholipids such as dipalmitoylphosphatidic acid
- zwitterionic phospholipids such as dipalmitoylphosphatidyl choline or fatty acids or corresponding long chain alkylsulfonic acids.
- the use of zwitterionic lipids enables the deposition of lipid multilayers on the shell.
- the application of polyelectrolytes in layers can for example be carried out as described in WO 99/47252.
- the layered assembly of the shells can for example be combined with the precipitation step according to the invention in such a manner that firstly a small number e.g. 1 to 4 layers of polyelectrolytes are layered onto the template particles which is followed by a precipitation step.
- a small number e.g. 1 to 4 layers of polyelectrolytes are layered onto the template particles which is followed by a precipitation step.
- a chemical reaction can also occur in or/and on the shells.
- the method according to the invention allows the production of capsules whose size distribution corresponds to that of emulsions and which in contrast to surfactant-stabilized systems, exhibit no change in their size distribution in the sense of an Ostwald maturation.
- the capsules are very stable towards chemical, biological, mechanical and thermal stress. If they have a suitable composition they can be dried and resuspended. They can be stored as a concentrate in aqueous or aqueous-gel like phases.
- FIG. 1 shows an embodiment of the method according to the invention comprising a one step formation of a polyelectrolyte/ion shell on colloidal liquid template particles.
- FIG. 2 shows another embodiment of the method according to the invention comprising a self-assembly of polymer films on the surface of colloidal liquid particles.
- FIGS. 1 and 2 show a schematic representation of two embodiments of the method according to the invention.
- a suspension of liquid template particles with added amphiphilic polyelectrolytes ( 2 ) is produced which contains metal ions e.g. ions of a polyvalent metal or ions of a noble metal such as Ag + ( 4 ).
- An ion/polyelectrolyte shell is precipitated on the template particles by dropwise addition of a solution containing negatively charged polyelectrolyte molecules ( 6 ).
- the coated template particles ( 8 ) can be further processed in various ways.
- empty capsules ( 10 ) can be produced by dissolution of the template particles.
- Metal-coated capsules ( 12 ) are obtained by reducing the metal ions.
- FIG. 2 Another embodiment of the method according to the invention is shown in FIG. 2.
- a suspension of colloidal liquid template particles with added amphiphilic polyelectrolytes ( 32 ) is placed in a liquid phase which contains a polymer e.g. a nucleic acid, a protein, a polysaccharide or a synthetic polymer in a dissolved form.
- the polymer is precipitated to form template particles ( 36 ) coated with the polymer by changing the solvent composition e.g. by the dropwise addition of ethanol or another solvent in which the polymer is insoluble or only poorly soluble.
- Deposition of layers of oppositely charged polyelectrolytes allows the production of coated template particles with an anisotropic shell ( 40 ) where the inner section of the shell is formed by the precipitated polymer and the outer section is formed by layers of oppositely charged polyelectrolytes. If soluble template particles are used it is possible to dissolve them to form a polymer ( 42 ) encapsulated in the polyelectrolyte/polyelectrolyte shell.
- the modified oil phase according to the instructions 1.1 to 1.5 is emulsified in aqueous solutions of suitable polyelectrolytes.
- the process is preferably continued using a polyanion in the aqueous phase in the case of 1.1, 1.3 and 1.4 and a polycation in the aqueous phase in the case of 1.2. 1.5 can be processed further in polycationic as well as in polyanionic systems.
- the resulting polyelectrolyte complexes in the oil/water phase boundary give the emulsion the necessary temporary stability towards coalescence and also stabilize the phase boundary itself so that it is possible to continue using known stepwise or one-step processes for the generation of polyelectrolyte multilayers.
- 1 ml oil (unmodified or modified with an amphiphilic polyelectrolyte as described in example 1.1 or 1.3) is emulsified with 5 ml poly(styrenesulfonate sodium salt) (PSS) having a molecular weight of 70,000 D from Aldrich (1 mg/ml in 0.5 M NaCl) by means of ultrasound e.g. with an Ultraturrax.
- PSS poly(styrenesulfonate sodium salt)
- PAH poly(allylamine hydrochloride) having a molecular weight of 50 to 65,000 D from Aldrich (1 mg/ml in 0.5 M NaCl) is admixed while shaking to generate a second layer.
- the third layer is formed by adding 15 ml PSS and the fourth layer is formed by adding 20 ml PAH.
- a total of up to 10 layers are formed in this manner.
- An initial solution of the two polyelectrolytes is prepared in which they are both present simultaneously in solution without reacting with one another. This is achieved by firstly adding 100 ml 0.1% (w/w) NaOH solution containing 0.1 M NaCl. 300 mg PSS (MW 70,000) and 200 mg PAH (MW 50-65,000) are successively dissolved in this solution. It is shaken until complete dissolution. This solution is stable for several hours. 20 ml oil (unmodified or modified according to formulations 1.1 to 1.5) is added. It is subsequently emulsified with an Ultraturrax and then rapidly titrated into the neutral range with 10% (w/w) HCl. The emulsion is subsequently purified e.g. washed several times in a separation funnel. This results in an emulsion which is stable for months.
- Solution I 1 ml PSS solution (2 mg/ml) is mixed with 200 ⁇ l of a Y(NO 3 ) 3 solution (2 ⁇ 10 ⁇ 2 M). The resulting charge ratio between sulfate and yttrium is 5:3.
- Solution II 400 ⁇ l oil is mixed with 1 ml water. The mixture is emulsified for 3 to 4 minutes with ultrasound in an Ultraturrax.
- Solution I is then rapidly added to solution II and the resulting emulsion is shaken in a vortex for 2 minutes.
- the emulsion is stable for more than 20 hours and can optionally be used as a starting system for further coatings.
Abstract
Description
- The invention concerns a method for applying a shell to liquid template particles.
- DE 198 12 083.4, DE 199 07 552.2, EP 98 113 181.6 and WO 99/47252 disclose a method for producing capsules coated with a polyelectrolyte shell by applying polyelectrolytes in layers on template particles. An advantage of this method over earlier methods for producing microcapsules is that it enables the production of monodisperse capsules having a defined wall thickness. Liquid template particles can also be coated. However, since liquid template particles have a relatively low stability, the object of the invention was to provide an improved process for coating liquid template particles which at least partially eliminates the disadvantages of the prior art.
- This object is achieved by a method for applying a shell to liquid template particles comprising the steps (a) providing an emulsion of liquid template particles in a continuous liquid or gel phase whereby at least one amphiphilic polyelectrolyte or polyelectrolyte complex or/and at least one copolymer of charged hydrophilic monomers and oil-soluble monomers is dissolved in the liquid template particles or/and the continuous phase thus forming a film at the phase boundary between the liquid template particle and the continuous phase and (b) applying a shell to the film formed at the phase boundary.
- It was surprisingly found that the formation of a film at the phase boundary between the liquid template particle and the continuous liquid or gel phase results in a stabilization of the liquid template particle which considerably facilitates the subsequent application of a shell.
- The encapsulation process according to the invention enables the encapsulation of any colloidal liquid particles e.g. emulsified oil droplets in a continuous aqueous or non-aqueous liquid phase. An oil phase is particularly preferably used as the liquid template particles and an aqueous phase e.g. a salt-containing aqueous solution in which the salt concentration is preferably between 0.001 mM and 1 M or more is particularly preferably used as the continuous liquid phase. Furthermore the process also allows the use of continuous gel phases and in particular aqueous gel phases.
- An essential feature of the present invention is that a film is formed at the boundary between the template particle and continuous liquid phase. If oil droplets are used as template particles, a polyelectrolyte or polyelectrolyte complex can be used for this purpose which is soluble in the oil phase. Alternatively or in addition the polyelectrolyte or polyelectrolyte complex can also be dissolved in the continuous liquid phase e.g. an aqueous phase. Furthermore it is also possible to use surface-active copolymers which contain monomers of different polarity.
- For example simplex compounds can be used as amphiphilic polyelectrolytes which contain (a) polycationic polymers and anions, for example monomeric anions such as salts of organic acids e.g. carboxylic acids or even polymeric anions such as polyacrylates or (b) polyanionic polymers and cations e.g. cationic monomers or polymers. The oleophilic behaviour of these types of compound can be influenced by the selection of the corresponding counterion for the polymer. Moreover it is also possible to use polyfunctional zwitterionic surfactants which are also amphiphilic compounds. In special cases it is possible to use combinations of polyfunctional surfactants and polyelectrolyte/counterion pairs. The concentration of the polyelectrolyte is preferably up to a maximum of 2% by weight, particularly preferably 0.01 to 1% by weight based on the total weight of the liquid template particle. Experience has shown that liquid template particles and in particular oil droplets which contain a combination of a simplex compound and a polyfunctional surfactant can be dispersed particularly well and droplets are obtained having a uniform size distribution. Furthermore the dispersions formed during the processing are more stable.
- Examples of amphiphilic polyelectrolytes are simplex compounds of polycations containing ammonium ions and hydrophobic organic anions such as the salts of organic acids e.g. carboxylic acids having 10 or more carbon atoms or polyanions such as polyacrylate or polymethacrylate. Specific examples are poly(diallyl-dimethyl)ammonium stearate, palmitate, oleate or ricinolate, poly[alkyl-methyl-bis(polyoxyethylene)-ammonium]-polyacrylate or poly[alkyl-dihydroxyethyl-ethyl-ammonium]-polyacrylate where the molecular weight of the polycation is preferably ≧150,000 D and particularly preferably ≧200,000 D. Examples of suitable polyfunctional surfactants are amphiphilic polymers with cationic ammonium groups and anionic sulfinate, sulfonate, sulfate, phosphonate, phosphate or/and carboxylate groups. Specific examples of suitable surfactants are alkyl-bis(polyoxyethylene)-ammonium-sulfobetaine-sulfinate, alkyl-bis(polyoxyethylene)-ammonium-sulfobetaine-sulfonate, ethylated alkyl- or dialkyl-ammonium betaine or alkyldimethyl-ammonium-propyl-modified polysiloxanes or siloxane-sulfobetaine-sulfones.
- The emulsion drops to be coated can have a size of up to 50 μm. However, the size of the drops is preferably up to 10 μm, particularly preferably 5 nm to 10 μm and most preferably 5 nm to 5 μm. The size of the drops can be adjusted by suitable treatment methods e.g. ultrasound, emulsification with a dispersing agent, extrusion or/and by adding surface-active substances to the continuous liquid phase.
- The liquid template particles may be a homogeneous liquid. They can, however, also comprise a solution, an emulsion or a suspension. Furthermore the liquid template particles can consist of a liquid-crystalline substance or contain such a substance. In a preferred embodiment template particles are encapsulated which contain an active substance e.g. they themselves represent an active substance. In general active substances can be encapsulated which are dissolved or dispersed in the liquid template particle. The active substance can for example be selected from catalysts, polymers, dyes, sensor molecules, flavourings, pharmaceutical agents, herbicides, insecticides, fungicides, oils in particular pharmaceutical or cosmetic oils e.g. perfume oils or solids that are soluble in oil or can be dispersed in oil, in particular pharmaceutical active substances.
- Organic liquids such as alcohols or hydrocarbons e.g. hexanol, octanol, octane or decane can also for example be encapsulated. Such capsules filled with an organic liquid that is not miscible with water can also be used for chemical reactions e.g. polymerization reactions. Hence the monomer can be concentrated specifically in the inner space of the capsules as a result of its distribution equilibrium. Optionally it is also possible to already enclose the monomer solution in the interior before the start of the synthesis.
- The method according to the invention enables the production of capsules for enclosing active substances. The inner space can be loaded with molecules by varying the permeability of the shell as a function of the external physical and chemical parameters. A state of high permeability is adjusted for loading purposes. The enclosed material is subsequently retained by changing the external parameters or/and closing the pores for example by condensing the shell or by chemical or/and thermal modification of the pores or channels.
- The method according to the invention allows charged or/and uncharged components to be deposited on the template particles. In a preferred embodiment of the invention the components required to form the shell contain at least one polyelectrolyte for example two oppositely charged polyelectrolytes or/and a polyvalent metal cation and a negatively charged polyelectrolyte.
- Polyelectrolytes are generally understood to mean polymers having ionically dissociable groups which may be a component or substituent of the polymer chain. The number of these ionically dissociable groups in the polyelectrolytes is usually large enough to ensure the water-solubility of the polymers in a dissociated form (also referred to as polyions). The term polyelectrolyte as used herein also refers to ionomers in which the concentration of the ionic groups is not sufficient to make them water soluble, but which have sufficient charges for a self-assembly. The shell preferably contains “true” polyelectrolytes. Polyelectrolytes are divided into polyacids and polybases depending on the type of the dissociable groups. Polyanions which can be inorganic as well as organic polymers are formed from polyacids when they dissociate with cleavage of protons.
- Polybases contain groups which are able to accept protons e.g. by reaction with acids to form salts. Polybases can have groups in the chains or side groups that are dissociable and form polycations by accepting protons.
- Polyelectrolytes that are suitable according to the invention are biopolymers such as alginic acid, gum arabic, nucleic acids, pectins, proteins and other biopolymers that may be chemically modified such as ionic or ionizable polysaccharides e.g. carboxymethyl cellulose, chitosan and chitosan sulfate, lignin sulfonates and synthetic polymers such as polymethacrylic acid, polyvinylsulfonic acid, polyvinylphosphonic acid and polyethyleneimine.
- Suitable polyanions comprise naturally occurring polyanions and synthetic polyanions. Examples of naturally occurring polyanions are alginate, carboxymethylamylose, carboxymethylcellulose, carboxymethyldextran, carageenan, cellulose sulfate, chrondroitin sulfate, chitosan sulfate, dextran sulfate, gum arabic, guar gum, gellan gum, heparin, hyaluronic acid, pectin, xanthan and proteins at an appropriate pH. Examples of synthetic polyanions are polyacrylates (salts of polyacrylic acid), anions of polyamino acids and copolymers thereof, polymaleinate, polymethacrylate, polystyrene sulfate, polystyrene sulfonate, polyvinyl phosphate, polyvinyl phosphonate, polyvinyl sulfate, polyacrylamidemethylpropane sulfonate, polylactate, poly(butanediene/maleinate), poly(ethylene/maleinate), poly(ethacrylate/acrylate) and poly(glycerylmethacrylate).
- Suitable polybases comprise naturally occurring polycations and synthetic polycations. Examples of suitable naturally occurring polycations are chitosan, modified dextrans, e.g. diethylaminoethyl-modified dextrans, hydroxymethylcellulose trimethylamine, lysozyme, polylysine, protamine sulfate, hydroxyethylcellulose trimethylamine and proteins at appropriate pH values. Examples of synthetic polycations are polyallyl-amine, polyallylamine hydrochloride, polyamines, polyvinylbenzyl-trimethyl-ammonium chloride, polybrene, polydiallyldimethylammonium chloride, poly-ethyleneimine, polyimidazoline, polyvinylamine, polyvinylpyridine, poly(acryl-amide/methacryloxypropyltrimethylammonium bromide), poly(diallyldimethyl-ammonium chloride/N-isopropylacrylamide), poly(dimethylaminoethylacrylate/acrylamide), polydimethylaminoethylmethacrylate, polydimethylaminoepichlorohydrin, polyethyleneiminoepichlorohydrin, polymethacryloxyethyltrimethylammonium bromide, hydroxypropylmethacryloxyethyldimethylammonium chloride, poly(methyldiethylaminoethylmethacrylate/acrylamide), poly(methyl/guanidine), polymethylvinylpyridinium bromide, poly(vinylpyrrolidone/dimethyl-aminoethylmethacrylate) and polyvinylmethylpyridinium bromide.
- Linear or branched polyelectrolytes can be used. The use of branched polyelectrolytes leads to less compact polyelectrolyte multifilms having a high degree of wall porosity. The capsule stability can be increased by cross-linking polyelectrolyte molecules within or/and between the individual layers e.g. by cross-linking amino groups with aldehydes.
- It is also possible to use amphiphilic polyelectrolytes, e.g. amphiphilic block or random copolymers having a partial polyelectrolyte character. Such amphiphilic copolymers consist of units of different functionality e.g. acidic or basic units on the one hand and hydrophobic units on the other hand such as styrenes, dienes or siloxanes etc. which can be arranged as blocks or randomly distributed over the polymer. The permeability or other properties of the capsule walls can be adjusted in a defined manner by using copolymers which change their structure as a function of the external conditions. These may for example be weak polyelectrolytes, polyampholytes or copolymers having a poly(N-isopropylacrylamide) component e.g. poly(N-isopropylacrylamide acrylic acid) which due to the equilibrium of hydrogen bridges, change their water solubility as a function of the temperature which is associated with swelling.
- The release of enclosed active substances can be regulated via the disintegration of the capsule walls by using polyelectrolytes that can be degraded under certain conditions e.g. photolabile, acid-labile, base-labile, salt-labile or thermolabile polyelectrolytes. Furthermore conductive polyelectrolytes or polyelectrolytes having optically active groups can be used as capsule components for special applications.
- The properties and composition of the polyelectrolyte shell of the capsules according to the invention can be adjusted in a defined manner by suitable selection of the polyelectrolytes. The composition of the shells can be varied over a wide range by selection of substances for the layer structure. There are basically no limitations with regard to the polyelectrolytes or ionomers that are used provided the molecules have a sufficient charge or/and the ability to bind to the underlying layer by other types of interaction such as hydrogen bonds and/or hydrophobic interactions.
- Hence suitable polyelectrolytes are low molecular polyelectrolytes or polyions and also macromolecular polyelectrolytes such as polyelectrolytes of biological origin.
- The permeability of the shell wall is of particular importance for the use of the capsules. As already stated above, the large number of polyelectrolytes that are available enables the production of numerous shell compositions having different properties. In particular the electric charge of the outer shell can be adapted to the intended use. Moreover the inner shell can be adapted to the respective encapsulated active substances which can for example lead to a stabilization of the active substance. Furthermore the permeability of the shell wall can be influenced by the selection of the polyelectrolytes in the shell and by the wall thickness as well as ambient conditions. This enables a selective design of the permeability properties and a defined change in these properties.
- The permeability properties of the shell can be further modified by pores in at least one of the polyelectrolyte layers. Such pores can be formed by the polyelectrolytes themselves if a suitable choice is made. In addition to the polyelectrolytes, the shell can also contain other substances in order to achieve a desired permeability. Thus the permeability to polar components can be lowered by incorporating nanoparticles having anionic or/and cationic groups or surface-active substances such as surfactants or/and lipids. The incorporation of selective transport systems such as carriers or channels in the polyelectrolyte shell and in particular in lipid layers enables an exact adaptation of the transversal transport properties of the shell to the respective intended use. The pores or channels of the shell wall can be opened or closed in a specific manner by chemical modification or/and change of the ambient conditions. Thus for example a high salt concentration of the surrounding medium leads to a high permeability of the shell wall.
- A first embodiment of the method according to the invention comprises the application of polyelectrolytes in layers on the liquid template particles that have been pretreated by adding amphiphilic polyelectrolytes. The application of polyelectrolytes in layers preferably comprises several and in particular more than four process steps in which oppositely charged polyelectrolytes are successively deposited from the continuous liquid phase onto the template particle.
- A second embodiment of the method according to the invention comprises a complex precipitation of multilayers or coacervation of several e.g. two oppositely charged polyelectrolytes. In this process the coating components in a complexed form are added first to the coating emulsion e.g. as complexes of two oppositely charged polyelectrolytes, and the components are transferred (redistributed) onto the boundary layer between the template particle and continuous phase by changing the media conditions. In order to carry out this process the film-forming components are for example kept in a solution e.g. in an alkaline solution in which the two are present simultaneously but without reacting with one another. The template particles to be coated are added to this solution. Subsequently it is titrated with acid, e.g. HCl, into the neutral range which results in an encapsulation of the template particles. After separation of the encapsulated particles from the complexes in the free solution e.g. by filtration, centrifugation, sedimentation (creaming) or phase separation, the template particles can be dissolved if necessary.
- In a further preferred embodiment the surface precipitation can occur from a solution containing a complex consisting of a low-molecular ion and an oppositely charged polyelectrolyte. Examples of suitable low-molecular ions are metal cations, inorganic anions such as sulfate, carbonate, phosphate, nitrate etc., charged surfactants, charged lipids and charged oligomers in combination with an appropriate oppositely charged polyelectrolyte. A dispersed source for the one polyelectrolyte is generated in this process while the other polyelectrolyte is present at the same time. The polyelectrolyte of the complex can be the polycation as well as the polyanion. The choice depends on the template particles used and other conditions. In this embodiment for example a positively charged polyelectrolyte with a multiply negatively charged low-molecular anion e.g. sulfate is added to a solution of the negatively charged polyelectrolyte and a suspension of the template particles which results in a coating of the template particles. The coated template particles can for example be separated from the free complexes by centrifugation, filtration and subsequent washing and—provided they are soluble particles—be dissolved to produce microcapsules.
- Another preferred embodiment comprises surface precipitation from a solution containing partially destabilized polyelectrolyte complexes (polycation/polyanion) by adding salt or/and pH variation. In this process there is a gradual transfer of polyelectrolytes from the complexes onto the template surface. This can be accomplished by introducing and stirring the negatively and positively charged polyelectrolyte in an aqueous solution having a high salt content preferably a salt content of ≧0.5 mol/l, e.g. 1 M NaCl. The template particles are coated after addition to the solution. The coated template particles can for example be isolated by centrifugation, filtration, sedimentation or other known phase separation methods and, subsequent washing and optionally dissolved to generate microcapsules.
- In yet another preferred embodiment the shell comprises low-molecular cations e.g. metal cations and at least one negatively charged polyelectrolyte. Divalent cations and in particular trivalent cations are for example used as cations. Examples of suitable cations are alkaline earth metal cations, transition metal cations and rare earth element cations such as Ca2+, Mg2+, Y3+, Tb3+ and Fe3+. On the other hand it is also possible to use monovalent cations such as Ag+. Template particles coated with a metal layer can be produced by reducing the metal cations.
- In yet another preferred embodiment the components that are necessary to form the shell comprise at least one macromolecule e.g. an abiogenic macromolecule such as an organic polymer or a biomolecule such as a nucleic acid e.g. DNA, RNA or a nucleic acid analogue, a polypeptide, a glycoprotein or a polysaccharide having a molecular weight of preferably ≧5 kD, and particularly preferably of ≧10 kD. The macromolecules can carry charges such as nucleic acids or be uncharged such as polysaccharides e.g. dextran. The macromolecules can optionally be combined with polyelectrolytes or/and polyvalent metal cations in which case combinations of macromolecular and low-molecular biological cell substances, macromolecular and low-molecular abiogenic substances and macromolecular and biogenic and abiogenic substances can for example be used.
- In yet a further preferred embodiment the components that are added to form the shell comprise a mixture of several polyelectrolytes or/and lipids or/and proteins or/and peptides or/and nucleic acids or/and other organic and inorganic compounds of biogenic or abiogenic origin. A suitable composition of the liquid continuous phase with regard to salt content, pH value, cosolvents, surfactants and a suitable selection of the coating conditions e.g. temperature, rheological conditions, presence of electrical or/and magnetic fields, presence of light etc. results in a self-assembly of the diverse shell components on the templates to form complex structures having a wide variety of biomimetic properties.
- The application according to step (b) of the method according to the invention occurs under conditions such that a shell of a defined thickness is formed around the template which is in the range of 1 to 100 nm, preferably 1 to 50 nm, particularly preferably 5 to 30 nm and most preferably 10 to 20 nm. When applied in layers, the wall thickness and the homogeneity of the capsule shell are determined by the number and composition of the layers and by the precipitation process, which essentially depends on the concentration of the template particles, the concentration of the coating components and the rate of the solubility change in the liquid phase which causes the precipitation.
- An application by means of precipitation can for example be carried out by firstly adding a part of the components forming the shell to the liquid phase and subsequently adding one or more additional shell components. Such a precipitation step can for example be used for a combination of metal cations and oppositely charged polyelectrolytes. Another method of precipitation is that the components required to form the shell are already completely present in the liquid phase and a change in the liquid phase occurs which results in the precipitation. This change in the liquid phase can for example comprise a change of the pH value and/or a change in the composition of the liquid phase e.g. by adding a solvent component or/and removing a solvent component. Thus for example hydrophilic biopolymers such as DNA or polysaccharides can be precipitated by adding ethanol to an aqueous liquid phase, whereas polyelectrolyte combinations can be precipitated by evaporating off an organic solvent such as acetone from the liquid phase.
- The components used to form the shell can alternatively or in addition also comprise nanoparticles e.g. organic or inorganic nanoparticles, in particular nanoparticles having electrical, magnetic or optical properties e.g. magnetite or CdTe.
- The coating method according to the invention can additionally comprise at least one additional coating step before or/and after the precipitation step. Such an additional coating step can for example comprise the application of one or more lipid layers or/and the application of layers of polyelectrolytes.
- The permeability of a shell can be modified by depositing lipid layers or/and amphiphilic polyelectrolytes on the polyelectrolyte shell. This can result in a very substantial reduction of the permeability of the shells to small and polar molecules. Examples of lipids that can be deposited on the shells are lipids which carry at least one ionic or ionogenic group e.g. phospholipids such as dipalmitoylphosphatidic acid or zwitterionic phospholipids such as dipalmitoylphosphatidyl choline or fatty acids or corresponding long chain alkylsulfonic acids. The use of zwitterionic lipids enables the deposition of lipid multilayers on the shell.
- The application of polyelectrolytes in layers can for example be carried out as described in WO 99/47252. The layered assembly of the shells can for example be combined with the precipitation step according to the invention in such a manner that firstly a small number e.g. 1 to 4 layers of polyelectrolytes are layered onto the template particles which is followed by a precipitation step. Alternatively or additionally it is also possible to deposit layers of polyelectrolytes on the shell after the precipitation steps. A chemical reaction can also occur in or/and on the shells.
- The method according to the invention allows the production of capsules whose size distribution corresponds to that of emulsions and which in contrast to surfactant-stabilized systems, exhibit no change in their size distribution in the sense of an Ostwald maturation. The capsules are very stable towards chemical, biological, mechanical and thermal stress. If they have a suitable composition they can be dried and resuspended. They can be stored as a concentrate in aqueous or aqueous-gel like phases.
- The invention is further elucidated by the following figures and examples.
- FIG. 1 shows an embodiment of the method according to the invention comprising a one step formation of a polyelectrolyte/ion shell on colloidal liquid template particles.
- FIG. 2 shows another embodiment of the method according to the invention comprising a self-assembly of polymer films on the surface of colloidal liquid particles.
- FIGS. 1 and 2 show a schematic representation of two embodiments of the method according to the invention. In FIG. 1 a suspension of liquid template particles with added amphiphilic polyelectrolytes (2) is produced which contains metal ions e.g. ions of a polyvalent metal or ions of a noble metal such as Ag+ (4). An ion/polyelectrolyte shell is precipitated on the template particles by dropwise addition of a solution containing negatively charged polyelectrolyte molecules (6). The coated template particles (8) can be further processed in various ways. Thus empty capsules (10) can be produced by dissolution of the template particles. Metal-coated capsules (12) are obtained by reducing the metal ions. By applying layers of oppositely charged polyelectrolytes (14 a, 14 b) it is possible to produce capsules with an anisotropic shell in which case the inner part is an ion/polyclectrolyte shell and the outer part is a polyelectrolyte/polyelectrolyte shell assembled in layers. Empty capsules (18) can be subsequently produced by dissolving the template particles. The inner ion/polyelectrolyte part of the shell can be dissolved by removing the metal ions (4) such that the polymer (6) is encapsulated in the interior of the shell formed (20) by the oppositely charged polyelectrolytes (14 a, 14 b).
- Another embodiment of the method according to the invention is shown in FIG. 2. A suspension of colloidal liquid template particles with added amphiphilic polyelectrolytes (32) is placed in a liquid phase which contains a polymer e.g. a nucleic acid, a protein, a polysaccharide or a synthetic polymer in a dissolved form. The polymer is precipitated to form template particles (36) coated with the polymer by changing the solvent composition e.g. by the dropwise addition of ethanol or another solvent in which the polymer is insoluble or only poorly soluble. Deposition of layers of oppositely charged polyelectrolytes (38 a, 38 b) allows the production of coated template particles with an anisotropic shell (40) where the inner section of the shell is formed by the precipitated polymer and the outer section is formed by layers of oppositely charged polyelectrolytes. If soluble template particles are used it is possible to dissolve them to form a polymer (42) encapsulated in the polyelectrolyte/polyelectrolyte shell.
- Preparation of Droplet Emulsions Stabilized by Amphiphilic Polyelectrolytes
- 1.1
- 0.1 g of a mixture of hexadecyl/octadecyl-bis(polyoxyethylene)-3-sulfopropyl-ammonium-betaine and sodium hexadecyl/octadecyl-bis(polyoxyethylene)-2-sulfinato-3-sulfopropyl-ammonium-betaine and poly(diallyldimethyl)ammonium-stearate (weight ratio of simplex compound to polyfunctional surfactant 2:1) is dissolved in 10 g oil.
- 1.2
- 0.05 g of a mixture composed of hexadecyl/octadecyl-bis(polyoxyethylene)-3-sulfopropyl-ammonium-betaine and sodium hexadecyl/octadecyl-bis(polyoxyethylene)-2-sulfinato-3-sulfopropyl-ammonium-betaine and poly[alkylmethyl-bis(polyoxyethylene)-ammonium]-polyacrylate (weight ratio of simplex compound to polyfunctional surfactant 2:1) is dissolved in 10 g oil.
- 1.3
- 0.05 g poly(diallyldimethyl)ammonium-poly(stearate) or poly(diallyldimethyl)-ammonium-poly(erucic acid) is dissolved in 10 g oil.
- 1.4
- 0.05 g alkyl-dimethyl-ammonium-propyl-modified polycationic polysiloxane is dissolved in 10 g oil.
- 1.5
- 0.02 g of a mixture of hexadecyl/octadecyl-bis(polyoxyethylene)-3-sulfopropyl-ammonium-betaine and sodium-hexadecyl/octadecyl-bis(polyoxyethylene)-2-sulfinato-3-sulfopropyl-ammonium-betaine is dissolved in 10 g oil.
- Layered Assembly of Polyelectrolyte Multilayers on Oil Droplets
- The modified oil phase according to the instructions 1.1 to 1.5 is emulsified in aqueous solutions of suitable polyelectrolytes. The process is preferably continued using a polyanion in the aqueous phase in the case of 1.1, 1.3 and 1.4 and a polycation in the aqueous phase in the case of 1.2. 1.5 can be processed further in polycationic as well as in polyanionic systems. The resulting polyelectrolyte complexes in the oil/water phase boundary give the emulsion the necessary temporary stability towards coalescence and also stabilize the phase boundary itself so that it is possible to continue using known stepwise or one-step processes for the generation of polyelectrolyte multilayers.
- 1 ml oil (unmodified or modified with an amphiphilic polyelectrolyte as described in example 1.1 or 1.3) is emulsified with 5 ml poly(styrenesulfonate sodium salt) (PSS) having a molecular weight of 70,000 D from Aldrich (1 mg/ml in 0.5 M NaCl) by means of ultrasound e.g. with an Ultraturrax. This results in the formation of a first polyelectrolyte double layer at the phase boundary between the emulsion droplets and the continuous aqueous phase.
- Subsequently 10 ml poly(allylamine hydrochloride) (PAH) having a molecular weight of 50 to 65,000 D from Aldrich (1 mg/ml in 0.5 M NaCl) is admixed while shaking to generate a second layer. The third layer is formed by adding 15 ml PSS and the fourth layer is formed by adding 20 ml PAH. A total of up to 10 layers (tenth layer 50 ml PAH) are formed in this manner.
- Multiple washing in a separating funnel results in stable emulsions. This can be optionally followed by cross-linking steps e.g. by glutardialdehyde.
- Complex Precipitation or Coacervation from Alkaline PSS/PAH Solution using Emulsion Droplets as the Template
- An initial solution of the two polyelectrolytes is prepared in which they are both present simultaneously in solution without reacting with one another. This is achieved by firstly adding 100 ml 0.1% (w/w) NaOH solution containing 0.1 M NaCl. 300 mg PSS (MW 70,000) and 200 mg PAH (MW 50-65,000) are successively dissolved in this solution. It is shaken until complete dissolution. This solution is stable for several hours. 20 ml oil (unmodified or modified according to formulations 1.1 to 1.5) is added. It is subsequently emulsified with an Ultraturrax and then rapidly titrated into the neutral range with 10% (w/w) HCl. The emulsion is subsequently purified e.g. washed several times in a separation funnel. This results in an emulsion which is stable for months.
- One-Step Precipitation from a Solution Containing a Complex of a Polyelectrolyte and a Multivalent Ion
- Solution I: 1 ml PSS solution (2 mg/ml) is mixed with 200 μl of a Y(NO3)3 solution (2×10−2 M). The resulting charge ratio between sulfate and yttrium is 5:3.
- Solution II: 400 μl oil is mixed with 1 ml water. The mixture is emulsified for 3 to 4 minutes with ultrasound in an Ultraturrax.
- Solution I is then rapidly added to solution II and the resulting emulsion is shaken in a vortex for 2 minutes. The emulsion is stable for more than 20 hours and can optionally be used as a starting system for further coatings.
Claims (25)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2000137707 DE10037707A1 (en) | 2000-08-02 | 2000-08-02 | Encapsulating liquid droplets, useful for pharmaceuticals, dyes or plant-protection agents, comprises first forming a polyelectrolyte film at the phase boundary of an emulsion |
DE10037707.6 | 2000-08-02 | ||
DE2000150382 DE10050382A1 (en) | 2000-10-11 | 2000-10-11 | Encapsulating liquid droplets, useful for pharmaceuticals, dyes or plant-protection agents, comprises first forming a polyelectrolyte film at the phase boundary of an emulsion |
DE10050382.9 | 2000-10-11 | ||
PCT/EP2001/008899 WO2002009864A1 (en) | 2000-08-02 | 2001-08-01 | Encapsulation of liquid template particles |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040013738A1 true US20040013738A1 (en) | 2004-01-22 |
Family
ID=26006594
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/343,670 Expired - Fee Related US7056554B2 (en) | 2000-08-02 | 2001-08-01 | Production of polyelectrolyte capsules by surface precipitation |
US10/343,583 Abandoned US20040013738A1 (en) | 2000-08-02 | 2001-08-01 | Encapsulation of liquid template particles |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/343,670 Expired - Fee Related US7056554B2 (en) | 2000-08-02 | 2001-08-01 | Production of polyelectrolyte capsules by surface precipitation |
Country Status (10)
Country | Link |
---|---|
US (2) | US7056554B2 (en) |
EP (2) | EP1305109B1 (en) |
JP (1) | JP2004504931A (en) |
AT (1) | ATE273067T1 (en) |
CA (1) | CA2417792C (en) |
DE (1) | DE50103245D1 (en) |
DK (1) | DK1305109T3 (en) |
ES (1) | ES2223914T3 (en) |
PT (1) | PT1305109E (en) |
WO (2) | WO2002009865A1 (en) |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050202149A1 (en) * | 2004-03-11 | 2005-09-15 | Mcclements David J. | Biopolymer encapsulation and stabilization of lipid systems and methods for utilization thereof |
US20060147543A1 (en) * | 2003-08-29 | 2006-07-06 | Haynie Donald T | Method for controlling stability of nanofabricated polypeptide multilayer films, coatings, and microcapsules |
US20060172909A1 (en) * | 2003-06-13 | 2006-08-03 | Peter Schmiedel | Peroxycarboxylic acid-based polyelectrolyte capsule system having a long shelf life |
US20060178285A1 (en) * | 2003-06-13 | 2006-08-10 | Peter Schmiedel | Peroxycaboxylic acid-based bleach compositions having a long shelf life |
US7101575B2 (en) * | 1998-03-19 | 2006-09-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
US20060260777A1 (en) * | 2005-04-27 | 2006-11-23 | Julia Rashba-Step | Surface-modified microparticles and methods of forming and using the same |
US20070032396A1 (en) * | 2003-06-13 | 2007-02-08 | Peter Schmiedel | Peroxycarboxylic acid-based capsules having a long shelf life |
US20070077276A1 (en) * | 2003-08-29 | 2007-04-05 | Haynie Donald T | Multilayer films, coatings, and microcapsules comprising polypeptides |
US20070077275A1 (en) * | 2003-08-29 | 2007-04-05 | Haynie Donald T | Multilayer films, coatings, and microcapsules comprising polypeptides |
US20070207210A1 (en) * | 2004-05-12 | 2007-09-06 | Brown Larry R | Protein Microspheres Retaining Pharmacokinetic and Pharmacodynamic Properties |
US20070281031A1 (en) * | 2006-06-01 | 2007-12-06 | Guohan Yang | Microparticles and methods for production thereof |
US20080020051A1 (en) * | 2004-03-19 | 2008-01-24 | Lars Dahne | Method For Producing Cs Particles And Microcapsules Using Porous Templates, Cs Particles And Microcapsules, And the Use Thereof |
US20080026068A1 (en) * | 2001-08-16 | 2008-01-31 | Baxter Healthcare S.A. | Pulmonary delivery of spherical insulin microparticles |
US20080039369A1 (en) * | 2006-08-04 | 2008-02-14 | Baxter International Inc. | Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
US20080248122A1 (en) * | 2006-10-06 | 2008-10-09 | Baxter International Inc. | Microencapsules Containing Surface-Modified Microparticles And Methods Of Forming And Using The Same |
US20100015068A1 (en) * | 2006-07-06 | 2010-01-21 | Massachusetts Institute Of Technology | Methods and Compositions For Altering Biological Surfaces |
US20100047903A1 (en) * | 2008-08-20 | 2010-02-25 | Baxter International Inc. | Methods of processing compositions containing microparticles |
US20100047248A1 (en) * | 2008-08-20 | 2010-02-25 | Baxter International Inc. | Methods of processing compositions containing microparticles |
US20100047292A1 (en) * | 2008-08-20 | 2010-02-25 | Baxter International Inc. | Methods of processing microparticles and compositions produced thereby |
US20100047162A1 (en) * | 2008-08-20 | 2010-02-25 | Baxter International Inc. | Methods of processing multi-phasic dispersons |
US20100305626A1 (en) * | 2008-01-24 | 2010-12-02 | University Of Utah Research Foundation | Adhesive complex coacervates and methods of making and using thereof |
CN104736688A (en) * | 2012-10-17 | 2015-06-24 | 宝洁公司 | Shape-changing droplet |
CN104736689A (en) * | 2012-10-17 | 2015-06-24 | 宝洁公司 | Non-spherical droplet |
US9173971B2 (en) | 2010-11-12 | 2015-11-03 | University Of Utah Research Foundation | Simple adhesive coacervates and methods of making and using thereof |
US9867899B2 (en) | 2010-05-24 | 2018-01-16 | University Of Utah Research Foundation | Reinforced adhesive complex coacervates and methods of making and using thereof |
US9913926B2 (en) | 2008-01-24 | 2018-03-13 | University Of Utah Research Foundation | Adhesive complex coacervates and method of making and using thereof |
US9913927B2 (en) | 2014-07-14 | 2018-03-13 | University Of Utah Research Foundation | In situ solidifying complex coacervates and methods of making and using thereof |
US10077324B2 (en) | 2013-02-06 | 2018-09-18 | Kci Licensing, Inc. | Polymers, preparation and use thereof |
US10710045B2 (en) * | 2012-01-31 | 2020-07-14 | Capsum | Capsules containing mammalian cells |
US11896234B2 (en) | 2018-01-26 | 2024-02-13 | Fluidx Medical Technology, Llc | Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002017888A2 (en) * | 2000-08-28 | 2002-03-07 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Controlled and sustained release properties of polyelectrolyte multilayer capsules |
EP1316558B9 (en) * | 2000-09-08 | 2005-12-07 | San-Ei Gen F.F.I., Inc. | Tetraphenylbacteriochlorin derivatives and compositions containing the same |
DE10127526A1 (en) * | 2001-05-31 | 2002-12-12 | Novosom Ag | Process for the preparation and dissolution of nano- and microcapsules |
DE10151290A1 (en) * | 2001-10-22 | 2003-04-30 | Roehm Gmbh | Process for the preparation of active ingredient-containing pellets |
US6837171B1 (en) | 2002-04-29 | 2005-01-04 | Palmer/Snyder Furniture Company | Lightweight table with unitized table top |
US20030119203A1 (en) * | 2001-12-24 | 2003-06-26 | Kimberly-Clark Worldwide, Inc. | Lateral flow assay devices and methods for conducting assays |
US7504364B2 (en) * | 2002-03-01 | 2009-03-17 | Receptors Llc | Methods of making arrays and artificial receptors |
US7153754B2 (en) * | 2002-08-29 | 2006-12-26 | Micron Technology, Inc. | Methods for forming porous insulators from “void” creating materials and structures and semiconductor devices including same |
US20040137481A1 (en) * | 2002-09-16 | 2004-07-15 | Receptors Llc | Artificial receptor building blocks, components, and kits |
US20050037381A1 (en) * | 2002-09-16 | 2005-02-17 | Receptors Llc | Artificial receptors, building blocks, and methods |
US20050136483A1 (en) * | 2003-09-03 | 2005-06-23 | Receptors Llc | Nanodevices employing combinatorial artificial receptors |
US20060057625A1 (en) * | 2002-09-16 | 2006-03-16 | Carlson Robert E | Scaffold-based artificial receptors and methods |
US7469076B2 (en) * | 2003-09-03 | 2008-12-23 | Receptors Llc | Sensors employing combinatorial artificial receptors |
DE10244503A1 (en) * | 2002-09-25 | 2004-04-08 | Capsulution Nanoscience Ag | Method for the preparation and stabilization of micro and nano suspensions with amphiphiles and polyelectrolytes |
DE10254636A1 (en) * | 2002-11-22 | 2004-06-09 | Capsulution Nanoscience Ag | Method for modifying microparticles and device for modifying microparticles |
US7781172B2 (en) | 2003-11-21 | 2010-08-24 | Kimberly-Clark Worldwide, Inc. | Method for extending the dynamic detection range of assay devices |
WO2004069169A2 (en) | 2003-01-31 | 2004-08-19 | Scimed Life Systems, Inc. | Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same |
EP1613737A4 (en) * | 2003-03-28 | 2008-12-03 | Receptors Llc | Artificial receptors including reversibly immobilized building blocks and methods |
US7364585B2 (en) | 2003-08-11 | 2008-04-29 | Boston Scientific Scimed, Inc. | Medical devices comprising drug-loaded capsules for localized drug delivery |
US7615530B2 (en) * | 2003-08-29 | 2009-11-10 | Artificial Cell Technologies, Inc. | Immunogenic compositions and methods of use |
WO2005057163A2 (en) * | 2003-10-20 | 2005-06-23 | William Marsh Rice University | Method to fabricate microcapsules from polymers and charged nanoparticles |
US7943395B2 (en) | 2003-11-21 | 2011-05-17 | Kimberly-Clark Worldwide, Inc. | Extension of the dynamic detection range of assay devices |
US7744644B2 (en) * | 2004-03-19 | 2010-06-29 | Boston Scientific Scimed, Inc. | Medical articles having regions with polyelectrolyte multilayer coatings for regulating drug release |
WO2005110592A1 (en) * | 2004-05-17 | 2005-11-24 | Yki, Ytkemiska Institutet Ab | Mesoporous particles loaded with active substance |
US7758892B1 (en) * | 2004-05-20 | 2010-07-20 | Boston Scientific Scimed, Inc. | Medical devices having multiple layers |
US8119153B2 (en) | 2004-08-26 | 2012-02-21 | Boston Scientific Scimed, Inc. | Stents with drug eluting coatings |
WO2006028930A2 (en) | 2004-09-03 | 2006-03-16 | Receptors Llc | Combinatorial artificial receptors including tether building blocks on scaffolds |
WO2006029383A2 (en) * | 2004-09-11 | 2006-03-16 | Receptors Llc | Combinatorial artificial receptors including peptide building blocks |
EP1808225B1 (en) * | 2004-10-18 | 2014-04-16 | Seiko Epson Corporation | Encapsulation product, process for producing the same, and ink composition |
ATE454134T1 (en) | 2005-04-13 | 2010-01-15 | Abbott Gmbh & Co Kg | METHOD FOR THE GENTLE PRODUCTION OF HIGHLY FINE PARTICLE SUSPENSIONS AND HIGHLY FINE PARTICLES AND THEIR USE |
JP4997408B2 (en) * | 2005-05-30 | 2012-08-08 | 独立行政法人産業技術総合研究所 | Hollow composite and method for producing the same |
US20070048383A1 (en) * | 2005-08-25 | 2007-03-01 | Helmus Michael N | Self-assembled endovascular structures |
EP2308900B1 (en) | 2005-10-25 | 2014-02-12 | Artificial Cell Technologies, Inc. | Immunogenic compositions and methods of use |
US7914891B2 (en) | 2005-12-28 | 2011-03-29 | Kimberly-Clark Worldwide, Inc. | Wipes including microencapsulated delivery vehicles and phase change materials |
US7497351B2 (en) | 2006-05-30 | 2009-03-03 | Kimberly-Clark Worldwide, Inc. | Wet wipe dispensing system |
US7654412B2 (en) | 2006-05-30 | 2010-02-02 | Kimberly-Clark Worldwide, Inc. | Wet wipe dispensing system for dispensing warm wet wipes |
US8192841B2 (en) | 2006-12-14 | 2012-06-05 | Kimberly-Clark Worldwide, Inc. | Microencapsulated delivery vehicle having an aqueous core |
WO2009016091A1 (en) * | 2007-08-01 | 2009-02-05 | Unilever Plc | Coated particles |
US20090043276A1 (en) * | 2007-08-09 | 2009-02-12 | Boston Scientific Scimed, Inc. | Drug delivery device, compositions and methods relating thereto |
US8431508B2 (en) * | 2007-10-30 | 2013-04-30 | Cerahelix, Inc. | Inorganic structure for molecular separations |
EP2103313A1 (en) * | 2008-03-19 | 2009-09-23 | Koninklijke Philips Electronics N.V. | Method for the synthesis of hollow spheres |
US7924142B2 (en) | 2008-06-30 | 2011-04-12 | Kimberly-Clark Worldwide, Inc. | Patterned self-warming wipe substrates |
WO2010086235A1 (en) | 2009-01-30 | 2010-08-05 | Unilever Plc | Oil-in-water emulsions |
CN102307654B (en) * | 2009-02-09 | 2015-01-21 | 切卢科技公司 | Polymer shells |
US8062555B2 (en) * | 2009-04-16 | 2011-11-22 | Rhodia Operations | Co-assembly method and co-assembled structures made thereby |
US9005662B2 (en) | 2009-08-20 | 2015-04-14 | The Florida State University Research Foundation, Inc. | Biocompatible polyelectrolyte complexes and methods of use |
RU2567320C2 (en) * | 2011-01-28 | 2015-11-10 | Учреждение Российской академии наук Институт теоретической и Экспериментальной биофизики РАН (ИТЭБ РАН) | Method of producing substrates with multilayer coating based on polyelectrolyte microcapsules containing biologically active materials |
EA201490485A1 (en) * | 2011-08-24 | 2014-06-30 | Унилевер Н.В. | PARTICLES FOR DELIVERY OF USEFUL AGENT, INCLUDING DEXTRAN |
BR112014004133B1 (en) * | 2011-08-24 | 2019-02-19 | Unilever N.V. | BENEFICIENT AGENT DISPOSAL, HAIR OR SKIN TREATMENT COMPOSITION, HAIR OR SKIN TREATMENT COMPOSITION AND BENEFICIAL AGENT PROCESSING PROCESS |
FR3013218B1 (en) * | 2013-11-18 | 2016-07-29 | Capsum | COMPOSITION COMPRISING BUFFER-STABILIZED GELIFIED CAPSULES |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4640709A (en) * | 1984-06-12 | 1987-02-03 | Monsanto Company | High concentration encapsulation by interfacial polycondensation |
US20030219384A1 (en) * | 1998-03-19 | 2003-11-27 | Edwin Donath | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE316420T1 (en) * | 1998-03-19 | 2006-02-15 | Max Planck Gesellschaft | PRODUCTION OF NANO AND MICRO CAPSULES BY LAYER-WIDE POLYELECTROLYTE SELF-ASSEMBLY |
EP0972563A1 (en) | 1998-07-15 | 2000-01-19 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates |
JP2003522621A (en) * | 1998-03-19 | 2003-07-29 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | Fabrication of multilayer coated particles and hollow shells by electrostatic self-assembly of nanocomposite multilayers on degradable colloid prototypes |
DE10001172A1 (en) | 2000-01-13 | 2001-07-26 | Max Planck Gesellschaft | Templating solid particles with polymer multilayers |
DE10010264A1 (en) * | 2000-03-02 | 2001-09-13 | Novosom Gmbh | Production of nano- or micro-capsules used in the production of liposomes coated with polyelectrolytes comprises electrically recharging template particles with polyelectrolytes |
-
2001
- 2001-08-01 US US10/343,670 patent/US7056554B2/en not_active Expired - Fee Related
- 2001-08-01 EP EP01969563A patent/EP1305109B1/en not_active Expired - Lifetime
- 2001-08-01 US US10/343,583 patent/US20040013738A1/en not_active Abandoned
- 2001-08-01 DE DE50103245T patent/DE50103245D1/en not_active Expired - Lifetime
- 2001-08-01 WO PCT/EP2001/008909 patent/WO2002009865A1/en active IP Right Grant
- 2001-08-01 AT AT01969563T patent/ATE273067T1/en not_active IP Right Cessation
- 2001-08-01 DK DK01969563T patent/DK1305109T3/en active
- 2001-08-01 EP EP01971841A patent/EP1307282A1/en not_active Withdrawn
- 2001-08-01 PT PT01969563T patent/PT1305109E/en unknown
- 2001-08-01 ES ES01969563T patent/ES2223914T3/en not_active Expired - Lifetime
- 2001-08-01 WO PCT/EP2001/008899 patent/WO2002009864A1/en not_active Application Discontinuation
- 2001-08-01 CA CA002417792A patent/CA2417792C/en not_active Expired - Fee Related
- 2001-08-01 JP JP2002515408A patent/JP2004504931A/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4640709A (en) * | 1984-06-12 | 1987-02-03 | Monsanto Company | High concentration encapsulation by interfacial polycondensation |
US20030219384A1 (en) * | 1998-03-19 | 2003-11-27 | Edwin Donath | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
Cited By (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8168226B2 (en) | 1998-03-19 | 2012-05-01 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
US8092836B2 (en) | 1998-03-19 | 2012-01-10 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
US7101575B2 (en) * | 1998-03-19 | 2006-09-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
US20060275373A1 (en) * | 1998-03-19 | 2006-12-07 | Edwin Donath | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
US20060275374A1 (en) * | 1998-03-19 | 2006-12-07 | Edwin Donath | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
US20080026068A1 (en) * | 2001-08-16 | 2008-01-31 | Baxter Healthcare S.A. | Pulmonary delivery of spherical insulin microparticles |
US20070032396A1 (en) * | 2003-06-13 | 2007-02-08 | Peter Schmiedel | Peroxycarboxylic acid-based capsules having a long shelf life |
US20060172909A1 (en) * | 2003-06-13 | 2006-08-03 | Peter Schmiedel | Peroxycarboxylic acid-based polyelectrolyte capsule system having a long shelf life |
US20060178285A1 (en) * | 2003-06-13 | 2006-08-10 | Peter Schmiedel | Peroxycaboxylic acid-based bleach compositions having a long shelf life |
US7531498B2 (en) | 2003-06-13 | 2009-05-12 | Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) | Peroxycarboxylic acid-based bleach compositions having a long shelf life |
US7411038B2 (en) | 2003-08-29 | 2008-08-12 | Louisiana Tech University Foundation | Artificial red blood cells |
US7550557B2 (en) | 2003-08-29 | 2009-06-23 | Louisiana Tech University Foundation, Inc. | Multilayer films, coatings, and microcapsules comprising polypeptides |
US20070077275A1 (en) * | 2003-08-29 | 2007-04-05 | Haynie Donald T | Multilayer films, coatings, and microcapsules comprising polypeptides |
US20060155482A1 (en) * | 2003-08-29 | 2006-07-13 | Haynie Donald T | Method for design of polypeptides for nanofabrication of multilayer films, coatings, and microcapsules |
US20090233074A1 (en) * | 2003-08-29 | 2009-09-17 | Louisiana Tech University Research Foundation, a division of the Louisiana Tech University | Multilayer Films, Coatings, and Microcapsules Comprising Polypeptides |
US7321022B2 (en) | 2003-08-29 | 2008-01-22 | Louisiana Tech University Foundation, Inc. | Method for controlling stability of nanofabricated polypeptide multilayer films, coatings, and microcapsules |
US7893198B2 (en) | 2003-08-29 | 2011-02-22 | Louisiana Tech University Foundation, Inc. | Multilayer films, coatings, and microcapsules comprising polypeptides |
US7544770B2 (en) | 2003-08-29 | 2009-06-09 | Louisiana Tech Foundation, Inc. | Multilayer films, coatings, and microcapsules comprising polypeptides |
US20070077276A1 (en) * | 2003-08-29 | 2007-04-05 | Haynie Donald T | Multilayer films, coatings, and microcapsules comprising polypeptides |
US7348399B2 (en) | 2003-08-29 | 2008-03-25 | Louisiana Tech University Foundation, Inc. | Nanofabricated polypeptide multilayer films, coatings, and microcapsules |
US7538184B2 (en) | 2003-08-29 | 2009-05-26 | Louisiana Tech University Foundation | Method for controlling stability of nanofabricated polypeptide multilayer films, coatings, and microcapsules |
US20060147543A1 (en) * | 2003-08-29 | 2006-07-06 | Haynie Donald T | Method for controlling stability of nanofabricated polypeptide multilayer films, coatings, and microcapsules |
US20060205005A1 (en) * | 2003-08-29 | 2006-09-14 | Haynie Donald T | Artificial red blood cells |
US7534860B2 (en) | 2003-08-29 | 2009-05-19 | Louisiana Tech University Foundation | Nanofabricated polypeptide multilayer films, coatings, and microcapsules |
US8137728B2 (en) * | 2004-03-11 | 2012-03-20 | University Of Massachusetts | Biopolymer encapsulation and stabilization of lipid systems and methods for utilization thereof |
US20050202149A1 (en) * | 2004-03-11 | 2005-09-15 | Mcclements David J. | Biopolymer encapsulation and stabilization of lipid systems and methods for utilization thereof |
US20080020051A1 (en) * | 2004-03-19 | 2008-01-24 | Lars Dahne | Method For Producing Cs Particles And Microcapsules Using Porous Templates, Cs Particles And Microcapsules, And the Use Thereof |
US8728525B2 (en) | 2004-05-12 | 2014-05-20 | Baxter International Inc. | Protein microspheres retaining pharmacokinetic and pharmacodynamic properties |
US20070207210A1 (en) * | 2004-05-12 | 2007-09-06 | Brown Larry R | Protein Microspheres Retaining Pharmacokinetic and Pharmacodynamic Properties |
US20060260777A1 (en) * | 2005-04-27 | 2006-11-23 | Julia Rashba-Step | Surface-modified microparticles and methods of forming and using the same |
US20070281031A1 (en) * | 2006-06-01 | 2007-12-06 | Guohan Yang | Microparticles and methods for production thereof |
US20100015068A1 (en) * | 2006-07-06 | 2010-01-21 | Massachusetts Institute Of Technology | Methods and Compositions For Altering Biological Surfaces |
US20080039369A1 (en) * | 2006-08-04 | 2008-02-14 | Baxter International Inc. | Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
US7964574B2 (en) | 2006-08-04 | 2011-06-21 | Baxter International Inc. | Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
US8389493B2 (en) | 2006-08-04 | 2013-03-05 | Baxter International Inc. | Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
US20080248122A1 (en) * | 2006-10-06 | 2008-10-09 | Baxter International Inc. | Microencapsules Containing Surface-Modified Microparticles And Methods Of Forming And Using The Same |
US20100305626A1 (en) * | 2008-01-24 | 2010-12-02 | University Of Utah Research Foundation | Adhesive complex coacervates and methods of making and using thereof |
US9272069B2 (en) | 2008-01-24 | 2016-03-01 | University Of Utah Research Foundation | Adhesive complex coacervates and methods of making and using thereof |
US9913926B2 (en) | 2008-01-24 | 2018-03-13 | University Of Utah Research Foundation | Adhesive complex coacervates and method of making and using thereof |
US10517987B2 (en) | 2008-01-24 | 2019-12-31 | University Of Utah Research Foundation | Adhesive complex coacervates and methods of making and using thereof |
RU2530653C2 (en) * | 2008-01-24 | 2014-10-10 | Юниверсити Оф Юта Рисерч Фаундейшн | Adhesive complex coacervates and methods for production and use thereof |
US20100047248A1 (en) * | 2008-08-20 | 2010-02-25 | Baxter International Inc. | Methods of processing compositions containing microparticles |
US8323685B2 (en) | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing compositions containing microparticles |
US8323615B2 (en) | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing multi-phasic dispersions |
US20100047903A1 (en) * | 2008-08-20 | 2010-02-25 | Baxter International Inc. | Methods of processing compositions containing microparticles |
US8367427B2 (en) | 2008-08-20 | 2013-02-05 | Baxter International Inc. | Methods of processing compositions containing microparticles |
US20100047162A1 (en) * | 2008-08-20 | 2010-02-25 | Baxter International Inc. | Methods of processing multi-phasic dispersons |
US20100047292A1 (en) * | 2008-08-20 | 2010-02-25 | Baxter International Inc. | Methods of processing microparticles and compositions produced thereby |
US9867899B2 (en) | 2010-05-24 | 2018-01-16 | University Of Utah Research Foundation | Reinforced adhesive complex coacervates and methods of making and using thereof |
US10653813B2 (en) | 2010-05-24 | 2020-05-19 | University Of Utah Research Foundation | Reinforced adhesive complex coacervates and methods of making and using thereof |
US9173971B2 (en) | 2010-11-12 | 2015-11-03 | University Of Utah Research Foundation | Simple adhesive coacervates and methods of making and using thereof |
US9421300B2 (en) | 2010-11-12 | 2016-08-23 | University Of Utah Research Foundation | Simple coacervates and methods of use thereof |
US9999700B1 (en) | 2010-11-12 | 2018-06-19 | University Of Utah Research Foundation | Simple coacervates and methods of use thereof |
US10710045B2 (en) * | 2012-01-31 | 2020-07-14 | Capsum | Capsules containing mammalian cells |
CN104736689A (en) * | 2012-10-17 | 2015-06-24 | 宝洁公司 | Non-spherical droplet |
CN104736688A (en) * | 2012-10-17 | 2015-06-24 | 宝洁公司 | Shape-changing droplet |
US10077324B2 (en) | 2013-02-06 | 2018-09-18 | Kci Licensing, Inc. | Polymers, preparation and use thereof |
US9913927B2 (en) | 2014-07-14 | 2018-03-13 | University Of Utah Research Foundation | In situ solidifying complex coacervates and methods of making and using thereof |
US10369249B2 (en) | 2014-07-14 | 2019-08-06 | University Of Utah Research Foundation | In situ solidifying complex coacervates and methods of making and using thereof |
US10729807B2 (en) | 2014-07-14 | 2020-08-04 | University Of Utah Research Foundation | In situ solidifying solutions and methods of making and using thereof |
US11471557B2 (en) | 2014-07-14 | 2022-10-18 | University Of Utah Research Foundation | In situ solidifying solutions and methods of making and using thereof |
US11896234B2 (en) | 2018-01-26 | 2024-02-13 | Fluidx Medical Technology, Llc | Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion |
Also Published As
Publication number | Publication date |
---|---|
US20030175517A1 (en) | 2003-09-18 |
ATE273067T1 (en) | 2004-08-15 |
JP2004504931A (en) | 2004-02-19 |
PT1305109E (en) | 2004-11-30 |
CA2417792A1 (en) | 2003-01-30 |
ES2223914T3 (en) | 2005-03-01 |
EP1305109B1 (en) | 2004-08-11 |
EP1307282A1 (en) | 2003-05-07 |
US7056554B2 (en) | 2006-06-06 |
CA2417792C (en) | 2009-09-08 |
EP1305109A1 (en) | 2003-05-02 |
WO2002009865A1 (en) | 2002-02-07 |
WO2002009864A1 (en) | 2002-02-07 |
DK1305109T3 (en) | 2004-12-20 |
DE50103245D1 (en) | 2004-09-16 |
WO2002009864A9 (en) | 2002-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040013738A1 (en) | Encapsulation of liquid template particles | |
US7101575B2 (en) | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly | |
EP1313455B1 (en) | Controlled and sustained release properties of polyelectrolyte multilayer capsules | |
EP1064087B1 (en) | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly | |
US6699501B1 (en) | Polyelectrolyte coverings on biological templates | |
EP1246692B1 (en) | Templating of uncharged solid particles by polymer multilayers | |
Remuñán-López et al. | Effect of formulation and process variables on the formation of chitosan-gelatin coacervates | |
Burgess | Complex coacervation: microcapsule formation | |
Shukla et al. | Emerging trend in nano-engineered polyelectrolyte-based surrogate carriers for delivery of bioactives | |
Shenoy et al. | Microgel‐Based Engineered Nanostructures and Their Applicability with Template‐Directed Layer‐by‐Layer Polyelectrolyte Assembly in Protein Encapsulation | |
DE10050382A1 (en) | Encapsulating liquid droplets, useful for pharmaceuticals, dyes or plant-protection agents, comprises first forming a polyelectrolyte film at the phase boundary of an emulsion | |
DE10037707A1 (en) | Encapsulating liquid droplets, useful for pharmaceuticals, dyes or plant-protection agents, comprises first forming a polyelectrolyte film at the phase boundary of an emulsion | |
Zheng et al. | Optimization and characterization of chitosan-coated alginate microcapsules containing albumin | |
Jain et al. | Ultrathin Multilayer Capsules in Drug Delivery. | |
JP3489033B2 (en) | Microcapsule and method for producing the same | |
Veerabadran | Nanoengineered templates for controlled delivery of bioactive compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSC Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VOIGT, ANDREAS;SUKHORUKOV, GLEB;ANTIPOV, ALEXEI;AND OTHERS;REEL/FRAME:014214/0213 Effective date: 20030122 |
|
AS | Assignment |
Owner name: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSC Free format text: DOCUMENT PREVIOUSLY RECORDED AT REEL 014214 FRAME 0213 CONTAINED ERRORS IN PROPERTY NUMBER 10343585. DOCUMENT RE-RECORDED TO CORRECT ERRORS ON STATED REEL.;ASSIGNORS:VOIGT, ANDREAS;SUKHORUKOV, GLEB;ANTIPOV, ALEXEI;AND OTHERS;REEL/FRAME:014244/0638;SIGNING DATES FROM 20030116 TO 20030122 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |